In this video:
Keynote Address: Dr Rajeev Singh Raghuvanshi, Secretary-cum-Scientific Director, Indian Pharmacopoeia Commission, Ministry of Health and Family Welfare, Govt. of India
Topic: Indian Pharmacopoeia – The Contextual Relevance
Key Highlights:
+ Newer techniques are improving sensitivity, accuracy of data generation while digitalisation and modelling are making Data Analysis more efficient in Pharma R&D
+ Pharma companies have to plan for contingencies and build new capabilites to survive and thrive in a complex and volatile environment
+ The quality of our Pharma and Medicinal products created for the domestic market have to improve and match global standards
+ Manufacturers and regulators have to join hands to rebuild our Quality Management Systems for domestic production of Pharma Products
+ IPC has initiated changes in 5 areas – IP-online, impurity limits – harmonising with ICH, dissolution for SR Products, flexible monographs and increasing inventory of impurity standards
Superb sir your dynamism will change the pace of Indian pharma industry through standard setting institute through IPC, Ghaziabad.Best wishes
Regards
Dr prasad thota